{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:20:09Z","timestamp":1790698809236,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s10792-022-02225-5","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T18:03:21Z","timestamp":1642615401000},"page":"2303-2310","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Psoriasis and uveitis"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9149-8083","authenticated-orcid":false,"given":"B\u00fc\u015fra","family":"K\u00f6se","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"Uzlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidayet","family":"Erd\u00f6l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,19]]},"reference":[{"issue":"1","key":"2225_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4103\/jfmpc.jfmpc_689_19","volume":"9","author":"J Rajguru","year":"2020","unstructured":"Rajguru J, Maya D, Kumar D, Suri P, Bhardwaj S, Patel N (2020) Update on psoriasis: a review. J Fam Med Prim Care 9(1):20","journal-title":"J Fam Med Prim Care"},{"key":"2225_CR2","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJMra0804595","volume":"361","author":"PO Frank Nestle","year":"2009","unstructured":"Frank Nestle PO, Kaplan DH, Barker J (2009) Psoriasis-mechanisms of disease. N Engl J Med 361:496\u2013509","journal-title":"N Engl J Med"},{"issue":"6","key":"2225_CR3","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1177\/1203475420952420","volume":"24","author":"M Lam","year":"2020","unstructured":"Lam M, Steen J, Di LuJ, Vender R (2020) The incidence and prevalence of uveitis in psoriasis: a systematic review and meta-analysis. J Cutan Med Surg 24(6):601\u2013607","journal-title":"J Cutan Med Surg"},{"key":"2225_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/PTT.S179182","volume":"9","author":"C Fotiadou","year":"2019","unstructured":"Fotiadou C, Lazaridou E (2019) Psoriasis and uveitis: links and risks. Psoriasis Targets Ther 9:91\u201396","journal-title":"Psoriasis Targets Ther"},{"issue":"6","key":"2225_CR5","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/ijms20061475","volume":"20","author":"A Rendon","year":"2019","unstructured":"Rendon A, Sch\u00e4kel K (2019) Psoriasis pathogenesis and treatment. Int J Mol Sci 20(6):1475","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2225_CR6","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.clindermatol.2019.07.029","volume":"37","author":"Z Demerdjieva","year":"2019","unstructured":"Demerdjieva Z, Mazhdrakova I, Tsankov N (2019) Ocular changes in patients with psoriasis. Clin Dermatol 37(6):663\u2013667","journal-title":"Clin Dermatol"},{"issue":"5","key":"2225_CR7","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/j.1365-4632.2011.05424.x","volume":"52","author":"B Kilic","year":"2013","unstructured":"Kilic B, Dogan U, Parlak AH, Goksugur N, Polat M, Serin D et al (2013) Ocular findings in patients with psoriasis. Int J Dermatol 52(5):554\u2013559","journal-title":"Int J Dermatol"},{"issue":"4","key":"2225_CR8","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jaad.2018.11.058","volume":"80","author":"CA Elmets","year":"2019","unstructured":"Elmets CA, Leonardi CL, Davis DMR, Gelfand JM, Lichten J, Mehta NN et al (2019) Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J Am Acad Dermatol 80(4):1073\u20131113","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"2225_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10792-014-9950-8","volume":"35","author":"A Campanati","year":"2015","unstructured":"Campanati A, Neri P, Giuliodori K, Arapi I, Carbonari G, Borioni E et al (2015) Psoriasis beyond the skin surface: a pilot study on the ocular involvement. Int Ophthalmol 35(3):331\u2013340","journal-title":"Int Ophthalmol"},{"issue":"2","key":"2225_CR10","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S0021-5155(00)00359-2","volume":"45","author":"F Okamoto","year":"2001","unstructured":"Okamoto F, Umebayasi Y, Ohtsuka F, Hommura S (2001) Factors associated with increased aqueous flare in psoriasis. Jpn J Ophthalmol 45(2):172\u2013176","journal-title":"Jpn J Ophthalmol"},{"issue":"6","key":"2225_CR11","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jaad.2010.10.032","volume":"65","author":"B Rehal","year":"2011","unstructured":"Rehal B, Modjtahedi BS, Morse LS, Schwab IR, Maibach HI (2011) Ocular psoriasis. J Am Acad Dermatol 65(6):1202\u20131212","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"2225_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/09273940802023786","volume":"16","author":"N Huynh","year":"2008","unstructured":"Huynh N, Cervantes-Castaneda RA, Bhat P, Gallagher MJ, Foster CS (2008) Biologic response modifier therapy for psoriatic ocular inflammatory disease. Ocul Immunol Inflamm 16(3):89\u201393","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"2225_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/09273940701299354","volume":"15","author":"M Cordero-Coma","year":"2007","unstructured":"Cordero-Coma M, Anzaar F, Sobrin L, Foster CS (2007) Systemic immunomodulatory therapy in severe dry eye secondary to inflammation. Ocul Immunol Inflamm 15(2):99\u2013104","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"2225_CR14","first-page":"280","volume":"137","author":"G Krueger","year":"2001","unstructured":"Krueger G, Koo J, Lebwohl M et al (2001) The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 137(3):280\u2013284","journal-title":"Arch Dermatol"},{"issue":"6","key":"2225_CR15","first-page":"299","volume":"57","author":"I Erbagci","year":"2003","unstructured":"Erbagci I, Erbagci Z, Gungor K, Bekir N (2003) Ocular anterior segment pathologies and tear film changes in patients with psoriasis vulgaris. Acta Med Okayama 57(6):299\u2013303","journal-title":"Acta Med Okayama"},{"issue":"3","key":"2225_CR16","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1046\/j.1365-2230.2001.00814.x","volume":"26","author":"R Ajitsaria","year":"2001","unstructured":"Ajitsaria R, Dale R, Ferguson V, Mayou S, Cavanagh N (2001) Psoriasis, psoriatic arthropathy and relapsing orbital myositis. Clin Exp Dermatol 26(3):274\u2013275","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"2225_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/09273948.2016.1196713","volume":"26","author":"T Tsirouki","year":"2018","unstructured":"Tsirouki T, Dastiridou A, Symeonidis C, Tounakaki O, Brazitikou I, Kalogeropoulos C et al (2018) A focus on the epidemiology of uveitis. Ocul Immunol Inflamm 26(1):2\u201316","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"2225_CR18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ajo.2004.08.053","volume":"139","author":"K Durrani","year":"2005","unstructured":"Durrani K, Foster CS (2005) Psoriatic uveitis: A distinct clinical entity? Am J Ophthalmol 139(1):106\u2013111","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"2225_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/jid.2012.339","volume":"133","author":"R Parisi","year":"2021","unstructured":"Parisi R, Symmons DPM, Griffiths CEM, Ashcroft DM (2021) Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol 133(2):377\u2013385","journal-title":"J Invest Dermatol"},{"key":"2225_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000479475","volume":"53","author":"L Puig","year":"2017","unstructured":"Puig L (2017) Paradoxical reactions: anti-tumor necrosis factor alpha agents, ustekinumab, secukinumab, ixekizumab, and others. Curr Probl Dermatol 53:49\u201363","journal-title":"Curr Probl Dermatol"},{"issue":"4","key":"2225_CR21","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/j.1756-185X.2012.01736.x","volume":"15","author":"L Niccoli","year":"2012","unstructured":"Niccoli L, Nannini C, Cassar\u00e0 E, Kaloudi O, Susini M, Lenzetti I et al (2012) Frequency of iridocyclitis in patients with early psoriatic arthritis: a prospective, follow up study. Int J Rheum Dis 15(4):414\u2013418","journal-title":"Int J Rheum Dis"},{"issue":"12","key":"2225_CR22","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/j.1346-8138.2007.00390.x","volume":"34","author":"NS Chandran","year":"2007","unstructured":"Chandran NS, Greaves M, Gao F, Lim L, Cheng BCL (2007) Psoriasis and the eye: prevalence of eye disease in Singaporean Asian patients with psoriasis. J Dermatol 34(12):805\u2013810","journal-title":"J Dermatol"},{"issue":"6","key":"2225_CR23","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1590\/S0365-05962012000600009","volume":"87","author":"NAA Fraga","year":"2012","unstructured":"Fraga NAA, Oliveira MPF, Follador I et al (2012) Psoriasis and uveitis: a literature review. An Bras Dermatol 87(6):877\u2013883","journal-title":"An Bras Dermatol"},{"issue":"1","key":"2225_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1136\/ard.59.1.67","volume":"59","author":"ES Paiva","year":"2000","unstructured":"Paiva ES, Macaluso DC, Edwards A, Rosenbaum JT (2000) Characterisation of uveitis in patients with psoriatic arthritis. Ann Rheum Dis 59(1):67\u201370","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"2225_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1159\/000246273","volume":"193","author":"S Iijima","year":"1996","unstructured":"Iijima S, Iwata M, Otsuka F (1996) Psoriatic arthritis and hypopyon-lridocyclitis. Dermatology 193(4):295\u2013299","journal-title":"Dermatology"},{"issue":"4","key":"2225_CR26","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1053\/sarh.2002.28798","volume":"31","author":"R Queiro","year":"2002","unstructured":"Queiro R, Torre JC, Belzunegui J, Gonz\u00e1lez C, De Dios JR, Unanue F et al (2002) Clinical features and predictive factors in psoriatic arthritis-related uveitis. Semin Arthritis Rheum 31(4):264\u2013270","journal-title":"Semin Arthritis Rheum"},{"issue":"2020","key":"2225_CR27","first-page":"9308341","volume":"15","author":"C Chaiyabutr","year":"2020","unstructured":"Chaiyabutr C, Ungprasert P, Silpa-Archa N, Wongpraparut C, Chularojanamontri L (2020) Psoriasis and risk of uveitis: a systematic review and meta-analysis. Biomed Res Int 15(2020):9308341","journal-title":"Biomed Res Int"},{"issue":"6","key":"2225_CR28","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.berh.2018.08.002","volume":"31","author":"SM Sharma","year":"2017","unstructured":"Sharma SM, Jackson D (2017) Uveitis and spondyloarthropathies. Best Pract Res Clin Rheumatol 31(6):846\u2013862","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"7","key":"2225_CR29","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00417-015-2968-4","volume":"253","author":"R Tanaka","year":"2015","unstructured":"Tanaka R, Takamoto M, Komae K, Ohtomo K, Fujino Y, Kaburaki T (2015) Clinical features of psoriatic uveitis in Japanese patients. Graefe\u2019s Arch Clin Exp Ophthalmol 253(7):1175\u20131180","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"issue":"6","key":"2225_CR30","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1080\/09273948.2016.1185528","volume":"25","author":"P Yang","year":"2017","unstructured":"Yang P, Zheng M, Zhang L, Du L, Zhou Q, Cai T et al (2017) Uveitis in Chinese patients with psoriasis. Ocul Immunol Inflamm 25(6):855\u2013865","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"2225_CR31","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1001\/jamaophthalmol.2017.0569","volume":"135","author":"CC Chi","year":"2017","unstructured":"Chi CC, Tung TH, Wang J, Lin YS, Chen YF, Hsu TK et al (2017) Risk of uveitis among people with psoriasis: a nationwide cohort study. JAMA Ophthalmol 135(5):415\u2013422","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"2225_CR32","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1001\/jamadermatol.2015.1986","volume":"151","author":"A Egeberg","year":"2015","unstructured":"Egeberg A, Khalid U, Gislason GH, Mallbris L, Skov L, Hansen PR (2015) Association of psoriatic disease with Uveitis: a danish nationwide cohort study. JAMA Dermatol 151(11):1200\u20131205","journal-title":"JAMA Dermatol"},{"issue":"5","key":"2225_CR33","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.jaad.2008.02.039","volume":"58","author":"A Menter","year":"2008","unstructured":"Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB et al (2008) Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 58(5):826\u2013850","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2225_CR34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/jdv.13813","volume":"31","author":"MA Radtke","year":"2017","unstructured":"Radtke MA, Sch\u00e4fer I, Glaeske G, Jacobi A, Augustin M (2017) Prevalence and comorbidities in adults with psoriasis compared to atopic eczema. J Eur Acad Dermatol Venereol 31(1):151\u2013157","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"2225_CR35","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s10792-016-0212-9","volume":"36","author":"FM T\u00fcrkc\u00fc","year":"2016","unstructured":"T\u00fcrkc\u00fc FM, \u015eahin A, Y\u00fcksel H, Akkurt M, U\u00e7mak D, \u00c7\u0131nar Y et al (2016) Evaluation of choroidal thickness in psoriasis using optical coherence tomography. Int Ophthalmol 36(6):851\u2013854","journal-title":"Int Ophthalmol"},{"issue":"10","key":"2225_CR36","first-page":"2075","volume":"4","author":"B Chowdhury","year":"2017","unstructured":"Chowdhury B, Pavaiya A, Khurana VK (2017) Ocular findings in psoriasis patients. Int J Contemporary Med Res 4(10):2075\u20132078","journal-title":"Int J Contemporary Med Res"},{"issue":"3","key":"2225_CR37","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/ICU.0000000000000466","volume":"29","author":"JE Weinstein","year":"2018","unstructured":"Weinstein JE, Pepple KL (2018) Cytokines in uveitis. Current opinion in ophthalmology. Curr Opin Ophthalmol 29(3):267\u2013274","journal-title":"Curr Opin Ophthalmol"},{"issue":"6","key":"2225_CR38","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.4049\/jimmunol.1600446","volume":"197","author":"J Zhang","year":"2016","unstructured":"Zhang J, Lin Y, Li C, Zhang X, Cheng L, Dai L et al (2016) IL-35 Decelerates the inflammatory process by regulating inflammatory cytokine secretion and M1\/M2 macrophage ratio in psoriasis. J Immunol 197(6):2131\u20132144","journal-title":"J Immunol"},{"issue":"1","key":"2225_CR39","doi-asserted-by":"publisher","first-page":"102429","DOI":"10.1016\/j.autrev.2019.102429","volume":"19","author":"JMG Ruiz de Morales","year":"2020","unstructured":"Ruiz de Morales JMG, Puig L, Daud\u00e9n E, Ca\u00f1ete JD, Pablos JL, Mart\u00edn AO et al (2020) Critical role of interleukin (IL)-17 in inflammatory and immune disorders: an updated review of the evidence focusing in controversies. Autoimmun Rev 19(1):102429","journal-title":"Autoimmun Rev"},{"issue":"2","key":"2225_CR40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.clim.2011.01.014","volume":"139","author":"AMA El-Asrar","year":"2011","unstructured":"El-Asrar AMA, Struyf S, Kangave D, Al-Obeidan SS, Opdenakker G, Geboes K et al (2011) Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis. Clin Immunol 139(2):177\u2013184","journal-title":"Clin Immunol"},{"issue":"6","key":"2225_CR41","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3109\/09273948.2013.815786","volume":"21","author":"S Jawad","year":"2013","unstructured":"Jawad S, Liu B, Agron E, Nussenblatt RB, Sen HN (2013) Elevated serum levels of interleukin-17A in uveitis patients. Ocul Immunol Inflamm 21(6):434\u2013439","journal-title":"Ocul Immunol Inflamm"},{"issue":"12","key":"2225_CR42","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/j.ophtha.2018.05.014","volume":"125","author":"KL Pepple","year":"2018","unstructured":"Pepple KL, Lin P (2018) Targeting Interleukin-23 in the treatment of noninfectious uveitis. Ophthalmology 125(12):1977\u20131983","journal-title":"Ophthalmology"},{"issue":"4","key":"2225_CR43","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1001\/jamaophthalmol.2015.5934","volume":"134","author":"G Velez","year":"2016","unstructured":"Velez G, Nathaniel Roybal C, Colgan D, Tsang SH, Bassuk AG, Mahajan VB (2016) Personalized proteomics for the diagnosis and treatment of idiopathic inflammatory disease. JAMA Ophthalmol 134(4):444\u2013448","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"2225_CR44","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1167\/iovs.07-1390","volume":"49","author":"W Chi","year":"2008","unstructured":"Chi W, Zhu X, Yang P, Liu X, Lin X, Zhou H et al (2008) Upregulated IL-23 and IL-17 in Beh\u00e7et patients with active uveitis. Investig Ophthalmol Vis Sci 49(7):3058\u20133064","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"8","key":"2225_CR45","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1136\/bjo.2009.169052","volume":"94","author":"S Jiang","year":"2010","unstructured":"Jiang S, Liu X, Luo L, Qu B, Huang X, Xu L et al (2010) Elevated serum IL-23 correlates with intraocular inflammation after cataract surgery in patients with Vogt-Koyanagi-Harada disease. Br J Ophthalmol 94(8):1078\u20131082","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"2225_CR46","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2174\/1566524015666150731100012","volume":"15","author":"W Chen","year":"2015","unstructured":"Chen W, Zhao B, Jiang R, Zhang R, Wang Y, Wu H et al (2015) Cytokine expression profile in aqueous humor and sera of patients with acute anterior uveitis. Curr Mol Med 15(6):543\u2013549","journal-title":"Curr Mol Med"},{"issue":"4","key":"2225_CR47","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3121\/cmr.4.4.294","volume":"4","author":"KGJ Ooi","year":"2006","unstructured":"Ooi KGJ, Galatowicz G, Calder VL, Lightman SL (2006) Cytokines and chemokines in uveitis - Is there a correlation with clinical phenotype. Clin Med Res 4(4):294\u2013309","journal-title":"Clin Med Res"},{"issue":"6","key":"2225_CR48","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/jid.2009.59","volume":"129","author":"A Di Cesare","year":"2009","unstructured":"Di Cesare A, Di Meglio P, Nestle FO (2009) The IL-23Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 129(6):1339\u20131350","journal-title":"J Invest Dermatol"},{"issue":"9","key":"2225_CR49","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00417-003-0706-9","volume":"241","author":"H Keino","year":"2003","unstructured":"Keino H, Sakai JI, Usui M (2003) Association between HLA-A2 in Japanese psoriasis arthritis and susceptibility to uveitis. Graefes Arch Clin Exp Ophthalmol 241(9):777\u2013778","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"2225_CR50","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00296-012-2649-0","volume":"34","author":"H Maejima","year":"2014","unstructured":"Maejima H, Watarai A, Nakano T, Katayama C, Nishiyama H, Katsuoka K (2014) Adverse effects of methotrexate in three psoriatic arthritis patients. Rheumatol Int 34(4):571\u2013574","journal-title":"Rheumatol Int"},{"issue":"1","key":"2225_CR51","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1586\/1744666X.2014.866038","volume":"10","author":"D Wendling","year":"2014","unstructured":"Wendling D, Prati C (2014) Paradoxical effects of anti-TNF-\u03b1 agents in inflammatory diseases. Exp Rev Clin Immunol 10(1):159\u2013169","journal-title":"Exp Rev Clin Immunol"},{"issue":"6","key":"2225_CR52","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1001\/jamaophthalmol.2017.0603","volume":"135","author":"J Sheppard","year":"2017","unstructured":"Sheppard J, Joshi A, Betts KA, Hudgens S, Tari S, Chen N et al (2017) Effect of adalimumab on visual functioning in patients with noninfectious intermediate uveitis, posterior uveitis, and panuveitis in the VISUAL-1 and VISUAL-2 Trials. JAMA Ophthalmol 135(6):511\u2013518","journal-title":"JAMA Ophthalmol"},{"issue":"9","key":"2225_CR53","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/S0161-6420(98)99033-9","volume":"105","author":"WJ Power","year":"1998","unstructured":"Power WJ, Rodriguez A, Pedroza-Seres M, Foster CS (1998) Outcomes in anterior uveitis associated with the HLA-B27 haplotype. Ophthalmology 105(9):1646\u20131651","journal-title":"Ophthalmology"},{"issue":"3","key":"2225_CR54","first-page":"524","volume":"31","author":"JF Mel\u00f3n","year":"2004","unstructured":"Mel\u00f3n JF, Fern\u00e1ndez SM, Hidalgo V (2004) Uveitis as the initial clinical manifestation in patients with spondyloarthropathies. J Rheumatol 31(3):524\u2013527","journal-title":"J Rheumatol"},{"issue":"6","key":"2225_CR55","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3109\/08820538.2016.1170161","volume":"32","author":"A Abbouda","year":"2017","unstructured":"Abbouda A, Abicca I, Fabiani C, Scappatura N, Pe\u00f1a-Garc\u00eda P, Scrivo R et al (2017) Psoriasis and psoriatic arthritis-related uveitis: different ophthalmological manifestations and ocular inflammation features. Semin Ophthalmol 32(6):715\u2013720","journal-title":"Semin Ophthalmol"},{"issue":"1","key":"2225_CR56","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3341\/kjo.2020.0131","volume":"35","author":"Y Lee","year":"2021","unstructured":"Lee Y, Oh BL, Yu HG, Youn SW, Woo SJ (2021) Clinical characteristics of uveitis in patients with psoriasis in korea: a retrospective multicenter case series. Korean J Ophthalmol 35(1):64\u201372","journal-title":"Korean J Ophthalmol"},{"issue":"3","key":"2225_CR57","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/bjd.12731","volume":"170","author":"E Burden-Teh","year":"2014","unstructured":"Burden-Teh E, Murphy R (2014) Psoriasis and uveitis - Should we be asking about eye symptoms? Br J Dermatol 170(3):756\u2013757","journal-title":"Br J Dermatol"},{"issue":"2","key":"2225_CR58","doi-asserted-by":"publisher","first-page":"102731","DOI":"10.1016\/j.autrev.2020.102731","volume":"20","author":"M Br\u00fcner","year":"2021","unstructured":"Br\u00fcner M, Dige A, Loft AG, Laurberg TB, Agnholt JS, Clemmensen K et al (2021) Spondylitis-psoriasis-enthesitis-enterocolitis-dactylitis-uveitis-peripheral synovitis (SPEED-UP) treatment. Autoimmun Rev 20(2):102731","journal-title":"Autoimmun Rev"},{"issue":"3","key":"2225_CR59","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.berh.2018.12.002","volume":"32","author":"A So","year":"2018","unstructured":"So A, Inman RD (2018) An overview of biologic disease-modifying antirheumatic drugs in axial spondyloarthritis and psoriatic arthritis. Best Pract Res Clin Rheumatol 32(3):453\u2013471","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"6","key":"2225_CR60","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/acr.22848","volume":"68","author":"M Rudwaleit","year":"2016","unstructured":"Rudwaleit M, Rosenbaum JT, Landew\u00e9 R, Marzo-Ortega H, Sieper J, Van Der Heijde D et al (2016) Observed incidence of uveitis following certolizumab pegol treatment in patients with axial spondyloarthritis. Arthritis Care Res 68(6):838\u2013844","journal-title":"Arthritis Care Res"},{"issue":"4","key":"2225_CR61","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/art.24403","volume":"60","author":"A Kavanaugh","year":"2009","unstructured":"Kavanaugh A, Mclnnes I, Mease P, Krueger GG, Gladman D, Gomez-Reino J et al (2009) Golimumab, a new human tumor necrosis factor \u03b1 antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: twenty-four-week efficacy and safety results of a randomized, placebo-controlled study. Arthritis Rheum 60(4):976\u2013986","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2225_CR62","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3899\/jrheum.180312","volume":"46","author":"RE van Bentum","year":"2019","unstructured":"van Bentum RE, Heslinga SC, Nurmohamed MT, Gerards AH, Griep EN, Koehorst CBJM et al (2019) Reduced occurrence rate of acute anterior uveitis in ankylosing spondylitis treated with golimumab - The go-easy study. J Rheumatol 46(2):153\u2013159","journal-title":"J Rheumatol"},{"issue":"5","key":"2225_CR63","doi-asserted-by":"publisher","first-page":"e12527","DOI":"10.1111\/dth.12527","volume":"30","author":"C Mugheddu","year":"2017","unstructured":"Mugheddu C, Atzori L, Del Piano M, Lappi A, Pau M, Murgia S et al (2017) Successful ustekinumab treatment of noninfectious uveitis and concomitant severe psoriatic arthritis and plaque psoriasis. Dermatol Ther 30(5):e12527","journal-title":"Dermatol Ther"},{"issue":"4","key":"2225_CR64","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.ophtha.2012.09.040","volume":"120","author":"AD Dick","year":"2013","unstructured":"Dick AD, Tugal-Tutkun I, Foster S, Zierhut M, Melissa Liew SH, Bezlyak V et al (2013) Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials. Ophthalmology 120(4):777\u2013787","journal-title":"Ophthalmology"},{"issue":"5","key":"2225_CR65","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.ophtha.2014.12.033","volume":"122","author":"E Letko","year":"2015","unstructured":"Letko E, Yeh S, Stephen Foster C, Pleyer U, Brigell M, Grosskreutz CL (2015) Efficacy and safety of intravenous secukinumab in noninfectious uveitis requiring steroid-sparing immunosuppressive therapy. Ophthalmology 122(5):939\u2013948","journal-title":"Ophthalmology"},{"key":"2225_CR66","doi-asserted-by":"crossref","unstructured":"Lu J, Tang S, Yu N, Yi X, Li Y (2020) Successful secukinumab treatment of erythrodermic psoriasis and psoriatic arthritis concomitant with severe noninfectious uveitis: a case report. J Int Med Res. 48(11)","DOI":"10.1177\/0300060520969494"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-022-02225-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-022-02225-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-022-02225-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T13:42:04Z","timestamp":1657892524000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-022-02225-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,19]]},"references-count":66,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["2225"],"URL":"https:\/\/doi.org\/10.1007\/s10792-022-02225-5","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,19]]},"assertion":[{"value":"1 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}